Track the prices of investigational drugs for COVID-19

COVID-19 has dominated all aspects of American and international life over the past months. As the scope of the disease becomes more apparent by the day, we have begun to monitor the impact that COVID-19 has had on prescription drug prices, and unsurprisingly, there’s been volatility. To facilitate broader investigation into the impact COVID-19, we wanted to share within the public domain the list of national drug codes (NDCs) that included active ingredients currently being investigated in conjunction with COVID-19 according to ClinicalTrials.gov. This new tool will give users the ability to better track prices of drugs that are being evaluated as potential treatments options. Here’s how we did it, and how you can use it.

Ben LinkApril 14, 2020COVID, Clinical Trial, Deferoxamine, Desferal